Private equity fit Candesic specializes in healthcare, pharma, life sciences and medtech management consulting and already works with global private equity funds and portfolio companies. This presents a sales opportunity to expand relationships with PE firms seeking due diligence, strategy and growth support across their healthcare portfolios.

Award momentum Recent wins and finalist status at Real Deals Private Equity Awards, LaingBuisson Awards, and HealthInvestor Awards enhance credibility. This can be leveraged to approach new clients and PE-backed platforms looking for trusted due diligence, strategy and growth advisory with proven recognition.

Global footprint With assignments across Europe, the Middle East, the Americas and Australia and a New York office expansion, Candesic demonstrates international reach. This is a selling point for multinational healthcare companies and funds seeking cross-border support and global market insights.

Niche expertise Deep integration of strategic, medical and scientific insight enables CEO-level clarity with R&D-level detail. Market to potential clients needing rigorous commercial due diligence, digital strategy, and M&A/growth support in life sciences and medtech.

Growth potential Revenue is in the small-to-mid market range with a 51-200 employee base, indicating agility and senior-accessible engagement. Position opportunities around faster decision cycles, boutique boutique-consulting advantages, and expansion projects for growing healthcare entities and PE-backed portfolios.